Sun Pharma Advanced Research Company Limited

SPARC

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 202630

    Quarter₹ croreYoY
    Sept 202413-39.3%
    Dec 202415+7.6%
    Mar 202527+64.2%
    Jun 202510-42.7%
    Sept 20258-38.9%
    Dec 20258-43.3%
    Mar 20261,853+6715.8%
    Jun 202640+314.1%
    Sept 202630+282.1%
  • ₹ crore

    Sept 202624

    Quarter₹ crore
    Sept 20240.04
    Dec 20240.19
    Mar 20250
    Jun 20259
    Sept 20250.01
    Dec 20250
    Mar 20262
    Jun 202624
    Sept 202624
  • ₹ crore

    Sept 202654

    Quarter₹ crore
    Sept 202413
    Dec 202415
    Mar 202527
    Jun 202519
    Sept 20258
    Dec 20258
    Mar 20261,855
    Jun 202664
    Sept 202654
  • Cost structure
  • ₹ crore

    Sept 202624

    Quarter₹ crore
    Sept 202429
    Dec 202426
    Mar 202525
    Jun 202528
    Sept 202526
    Dec 202527
    Mar 202621
    Jun 202624
    Sept 202624
  • ₹ crore

    Sept 202678

    Quarter₹ crore
    Sept 2024121
    Dec 202495
    Mar 202588
    Jun 202571
    Sept 202584
    Dec 202577
    Mar 202694
    Jun 202685
    Sept 202678
  • Exceptional items and tax
  • ₹ crore

    Sept 2026-25

    Quarter₹ crore
    Sept 2024-108
    Dec 2024-80
    Mar 2025-61
    Jun 2025-52
    Sept 2025-76
    Dec 2025-81
    Mar 20261,761
    Jun 2026-21
    Sept 2026-25
  • ₹ crore

    Sept 20260

    Quarter₹ crore
    Sept 20240
    Dec 20240
    Mar 20250
    Jun 20250
    Sept 20250
    Dec 20250
    Mar 20260
    Jun 20260
    Sept 20260
  • Profit
  • ₹ crore

    Sept 2026-25

    Quarter₹ croreYoY
    Sept 2024-108-24.6%*
    Dec 2024-80+20.0%*
    Mar 2025-61+42.8%*
    Jun 2025-52+46.3%*
    Sept 2025-76+29.5%*
    Dec 2025-81-1.1%*
    Mar 20261,761+2987.3%*
    Jun 2026-21+59.7%*
    Sept 2026-25+67.6%*
  • Per share
  • ₹ per share

    Sept 2026-0.76

    Quarter₹ per share
    Sept 2024-3.32
    Dec 2024-2.46
    Mar 2025-1.88
    Jun 2025-1.60
    Sept 2025-2.34
    Dec 2025-2.48
    Mar 202654.26
    Jun 2026-0.65
    Sept 2026-0.76
  • Leverage
  • Debt to equity

    times

    Sept 20260.00x

    Quartertimes
    Sept 2024—
    Dec 2024—
    Mar 20250.00x
    Jun 2025—
    Sept 20250.00x
    Dec 2025—
    Mar 20260.00x
    Jun 20260.00x
    Sept 20260.00x
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
13152710881,8534030
Revenue YoY-39.3%+7.6%+64.2%-42.7%-38.9%-43.3%+6715.8%+314.1%+282.1%
0.040.19090.01022424
13152719881,8556454
Cost structure
292625282627212424
1219588718477948578
Exceptional items and tax
-108-80-61-52-76-811,761-21-25
000000000
Profit
-108-80-61-52-76-811,761-21-25
Net profit YoY-24.6%*+20.0%*+42.8%*+46.3%*+29.5%*-1.1%*+2987.3%*+59.7%*+67.6%*
Per share
-3.32-2.46-1.88-1.60-2.34-2.4854.26-0.65-0.76
Leverage
Debt to equity——0.00x—0.00x—0.00x0.00x0.00x

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.